Status:

COMPLETED

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

University of California, San Francisco

Conditions:

Idiopathic Pulmonary Fibrosis

Eligibility:

All Genders

18-85 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether low concentration inhaled carbon monoxide is effective in treating idiopathic pulmonary fibrosis.

Detailed Description

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by destruction of normal epithelial structure, proliferation of fibroblasts, and deposition of connective-tissue matri...

Eligibility Criteria

Inclusion

  • Adults above the age of 18 and equal to or below the age of 85
  • Diagnosis of IPF by biopsy or
  • American Thoracic Society (ATS)/European Respiratory Society (ERS)/ Latin American Thoracic Association (ALAT) Guidelines (Am J Respir Crit Care Med Vol 183. pp 788-824,2011)
  • Forced vital capacity (FVC) greater than or equal to 50% predicted, greater than or equal to one month off all medications prescribed for IPF

Exclusion

  • Evidence of active infection within the last month
  • Significant obstructive respiratory defect
  • Supplemental oxygen required to maintain an oxygen saturation over 88% at rest
  • History of myocardial infarction within the last year, heart failure within the last 3 years or cardiac arrhythmia requiring drug therapy
  • History of smoking within 4 weeks of screening
  • Pregnancy or lactation
  • Participation in another therapeutic clinical trial

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT01214187

Start Date

July 1 2011

End Date

April 1 2015

Last Update

June 14 2017

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

University of California San Francisco

San Francisco, California, United States, 94143

2

University of Illinois Chicago

Chicago, Illinois, United States, 60612

3

University of Chicago

Chicago, Illinois, United States, 60637

4

Tulane University

New Orleans, Louisiana, United States, 70112

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis | DecenTrialz